233 related articles for article (PubMed ID: 23230756)
1. [Impact of topical application of autologous platelet-rich gel on medical expenditure and length of stay in hospitals in diabetic patients with refractory cutaneous ulcers].
Li L; Wang C; Wang Y; He LP; Yang YZ; Chen LH; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):762-5. PubMed ID: 23230756
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic changes of MMP-1, MMP-9 and TIMP-1 in the refractory diabetic dermal ulcers treated by autologous Platelet-rich gel].
He LP; Wang C; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):757-61. PubMed ID: 23230755
[TBL] [Abstract][Full Text] [Related]
3. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial.
Li L; Chen D; Wang C; Yuan N; Wang Y; He L; Yang Y; Chen L; Liu G; Li X; Ran X
Wound Repair Regen; 2015; 23(4):495-505. PubMed ID: 25847503
[TBL] [Abstract][Full Text] [Related]
4. [Application of autologous platelet-rich gel to refractory chronic diabetic cutaneous ulcers].
Yuan N; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Apr; 21(4):426-9. PubMed ID: 17546893
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
6. [The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer].
Yuan NB; Wang C; Wang Y; Yu TT; Shu SQ; Liu M; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):900-3. PubMed ID: 17953386
[TBL] [Abstract][Full Text] [Related]
7. [Study on the mechanism of autologous platelet-rich gel to treat the refractory diabetic dermal ulcers].
Yuan NB; Long Y; Zhang XX; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):292-4. PubMed ID: 19462910
[TBL] [Abstract][Full Text] [Related]
8. Autologous platelet-rich gel treatment for diabetic chronic cutaneous ulcers: A meta-analysis of randomized controlled trials.
Li Y; Gao Y; Gao Y; Chen D; Wang C; Liu G; Yang X; Ran X
J Diabetes; 2019 May; 11(5):359-369. PubMed ID: 30182534
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program.
Sakata J; Sasaki S; Handa K; Uchino T; Sasaki T; Higashita R; Tsuno N; Hiyoshi T; Morimoto S; Rinoie C; Saito N
Ostomy Wound Manage; 2012 Apr; 58(4):36-49. PubMed ID: 22466132
[TBL] [Abstract][Full Text] [Related]
10. Autologous Platelet-Rich Gel for the Treatment of Diabetic Sinus Tract Wounds: A Clinical Study.
Xie J; Fang Y; Zhao Y; Cao D; Lv Y
J Surg Res; 2020 Mar; 247():271-279. PubMed ID: 31706541
[TBL] [Abstract][Full Text] [Related]
11. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers.
Ahmed M; Reffat SA; Hassan A; Eskander F
Ann Vasc Surg; 2017 Jan; 38():206-211. PubMed ID: 27522981
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.
Dougherty EJ
Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083
[TBL] [Abstract][Full Text] [Related]
13. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series.
Frykberg RG; Driver VR; Carman D; Lucero B; Borris-Hale C; Fylling CP; Rappl LM; Clausen PA
Ostomy Wound Manage; 2010 Jun; 56(6):36-44. PubMed ID: 20567053
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.
Jude EB; Apelqvist J; Spraul M; Martini J;
Diabet Med; 2007 Mar; 24(3):280-8. PubMed ID: 17305788
[TBL] [Abstract][Full Text] [Related]
15. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
[TBL] [Abstract][Full Text] [Related]
16. Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.
Akingboye AA; Giddins S; Gamston P; Tucker A; Navsaria H; Kyriakides C
J Extra Corpor Technol; 2010 Mar; 42(1):20-9. PubMed ID: 20437788
[TBL] [Abstract][Full Text] [Related]
17. Autologous platelet gel in total knee arthroplasty: a prospective randomized study.
Horstmann WG; Slappendel R; van Hellemondt GG; Wymenga AW; Jack N; Everts PA
Knee Surg Sports Traumatol Arthrosc; 2011 Jan; 19(1):115-21. PubMed ID: 20640848
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.
Driver VR; Hanft J; Fylling CP; Beriou JM;
Ostomy Wound Manage; 2006 Jun; 52(6):68-70, 72, 74 passim. PubMed ID: 16799184
[TBL] [Abstract][Full Text] [Related]
19. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers.
Alio JL; Abad M; Artola A; Rodriguez-Prats JL; Pastor S; Ruiz-Colecha J
Ophthalmology; 2007 Jul; 114(7):1286-1293.e1. PubMed ID: 17324465
[TBL] [Abstract][Full Text] [Related]
20. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
